The results of Gene Expression Omnibus and The Cancer Genome Atlas database analysis have shown that GNA12 can be used as a biomarker for the personalized treatment of head and neck squamous cell carcinoma (HNSCC) patients and one of the prognostic genes for patients with HNSCC (Liu et al., 2021). Here, GNA12 is linked to head and neck squamous cell carcinoma.